These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Nicotine use in schizophrenia and disinhibition. Dervaux A; Baylé FJ; Laqueille X; Bourdel MC; Le Borgne MH; Olié JP; Krebs MO Psychiatry Res; 2004 Oct; 128(3):229-34. PubMed ID: 15541779 [TBL] [Abstract][Full Text] [Related]
7. Differences in prevalence and patterns of substance use in schizophrenia and bipolar disorder. Ringen PA; Lagerberg TV; Birkenaes AB; Engn J; Faerden A; Jónsdottir H; Nesvåg R; Friis S; Opjordsmoen S; Larsen F; Melle I; Andreassen OA Psychol Med; 2008 Sep; 38(9):1241-9. PubMed ID: 18070373 [TBL] [Abstract][Full Text] [Related]
8. Dimensions of psychosis in patients with bipolar mania as measured by the positive and negative syndrome scale. Lindenmayer JP; Bossie CA; Kujawa M; Zhu Y; Canuso CM Psychopathology; 2008; 41(4):264-70. PubMed ID: 18441528 [TBL] [Abstract][Full Text] [Related]
9. Cigarette smoking topography in smokers with schizophrenia and matched non-psychiatric controls. Tidey JW; Rohsenow DJ; Kaplan GB; Swift RM Drug Alcohol Depend; 2005 Nov; 80(2):259-65. PubMed ID: 15869844 [TBL] [Abstract][Full Text] [Related]
10. Tobacco smoking behaviors in bipolar disorder: a comparison of the general population, schizophrenia, and major depression. Diaz FJ; James D; Botts S; Maw L; Susce MT; de Leon J Bipolar Disord; 2009 Mar; 11(2):154-65. PubMed ID: 19267698 [TBL] [Abstract][Full Text] [Related]
12. Neurocognitive and clinical predictors of functional outcome in patients with schizophrenia and bipolar I disorder at one-year follow-up. Tabarés-Seisdedos R; Balanzá-Martínez V; Sánchez-Moreno J; Martinez-Aran A; Salazar-Fraile J; Selva-Vera G; Rubio C; Mata I; Gómez-Beneyto M; Vieta E J Affect Disord; 2008 Aug; 109(3):286-99. PubMed ID: 18289698 [TBL] [Abstract][Full Text] [Related]
13. [Schizophrenia and bipolar disorders: clinical dimensions]. Thomas P Encephale; 2009 Oct; 35 Suppl 5():S142-5. PubMed ID: 19909834 [No Abstract] [Full Text] [Related]
14. Measurement of insight in patients with bipolar disorder: are self-rated scales developed for patients with schizophrenia applicable? Jónsdóttir H; Engh JA; Friis S; Birkenaes A; Ringen PA; Vaskinn A; Sundet K; Opjordsmoen S; Andreassen OA J Nerv Ment Dis; 2008 Apr; 196(4):333-5. PubMed ID: 18414129 [TBL] [Abstract][Full Text] [Related]
16. Adverse childhood experiences, smoking and mental illness in adulthood: a preliminary study. Sacco KA; Head CA; Vessicchio JC; Easton CJ; Prigerson HG; George TP Ann Clin Psychiatry; 2007; 19(2):89-97. PubMed ID: 17612848 [TBL] [Abstract][Full Text] [Related]
17. No evidence for physical anhedonia as a candidate symptom or an endophenotype in bipolar affective disorder. Etain B; Roy I; Henry C; Rousseva A; Schürhoff F; Leboyer M; Bellivier F Bipolar Disord; 2007 Nov; 9(7):706-12. PubMed ID: 17988360 [TBL] [Abstract][Full Text] [Related]
18. Comparison of older patients with bipolar disorder and schizophrenia/schizoaffective disorder. Gupta S; Steinmeyer CH; Lockwood K; Lentz B; Schultz K Am J Geriatr Psychiatry; 2007 Jul; 15(7):627-33. PubMed ID: 17586787 [TBL] [Abstract][Full Text] [Related]
19. The effect of anxiety disorder comorbidity on treatment resistant bipolar disorders. Lee JH; Dunner DL Depress Anxiety; 2008; 25(2):91-7. PubMed ID: 17311265 [TBL] [Abstract][Full Text] [Related]
20. Prevalence of Toxoplasma infection in first-episode schizophrenia and comparison between Toxoplasma-seropositive and Toxoplasma-seronegative schizophrenia. Wang HL; Wang GH; Li QY; Shu C; Jiang MS; Guo Y Acta Psychiatr Scand; 2006 Jul; 114(1):40-8. PubMed ID: 16774660 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]